title: Effect on hematologic risk factors for coronary heart disease of a cholesterol reducing diet.
abstract: BACKGROUND
  A dietary portfolio of cholesterol-lowering ingredients has proved effective in reducing serum cholesterol. However, it is not known whether this dietary combination will also affect hematologic risk factors for coronary heart disease (CHD). Reductions in hematocrit and polymorphonuclear leukocytes have been reported to improve cardiovascular risk. We, therefore, report changes in hematological indices, which have been linked to cardiovascular health, in a 1-year assessment of subjects taking an effective dietary combination (portfolio) of cholesterol-lowering foods.
  
  
  METHODS
  For 12 months, 66 hyperlipidemic subjects were prescribed diets high in plant sterols (1.0 g/1000 kcal), soy protein (22.5 g/1000 kcal), viscous fibers (10 g/1000 kcal) and almonds (23 g/1000 kcal). Fifty-five subjects completed the study.
  
  
  RESULTS
  Over the 1 year, data on completers indicated small but significant reductions in hemoglobin (-1.5+/-0.6 g/l, P=0.013), hematocrit (-0.007+/-0.002 l/l, P<0.001), red cell number (-0.07+/-0.02 10(9)/l, P<0.001) and neutrophils (-0.34+/-0.13 10(9)/l, P=0.014). Mean platelet volume was also increased (0.16+/-0.07 fl, P=0.033). The increase in red cell osmotic fragility (0.05+/-0.03 g/l, P=0.107) did not reach significance.
  
  
  CONCLUSIONS
  These small changes in hematological indices after a cholesterol-lowering diet are in the direction, which would be predicted to reduce CHD risk. Further research is needed to clarify whether the changes observed will contribute directly or indirectly to cardiovascular benefits beyond those expected from reductions previously seen in serum lipids and blood pressure.
authors.affiliation: Division of Endocrinology and Metabolism, Clinical Nutrition & Risk Factor Modification Center, St Michael's Hospital, Toronto, Ontario, Canada.
authors.forename: D J A
authors.initials: DJ
authors.lastname: Jenkins
authors.forename: C W C
authors.initials: CW
authors.lastname: Kendall
authors.forename: T H
authors.initials: TH
authors.lastname: Nguyen
authors.forename: J
authors.initials: J
authors.lastname: Teitel
authors.forename: A
authors.initials: A
authors.lastname: Marchie
authors.forename: M
authors.initials: M
authors.lastname: Chiu
authors.forename: A Y
authors.initials: AY
authors.lastname: Taha
authors.forename: D A
authors.initials: DA
authors.lastname: Faulkner
authors.forename: T
authors.initials: T
authors.lastname: Kemp
authors.forename: J M W
authors.initials: JM
authors.lastname: Wong
authors.forename: R
authors.initials: R
authors.lastname: de Souza
authors.forename: A
authors.initials: A
authors.lastname: Emam
authors.forename: E A
authors.initials: EA
authors.lastname: Trautwein
authors.forename: K G
authors.initials: KG
authors.lastname: Lapsley
authors.forename: C
authors.initials: C
authors.lastname: Holmes
authors.forename: R G
authors.initials: RG
authors.lastname: Josse
authors.forename: L A
authors.initials: LA
authors.lastname: Leiter
authors.forename: W
authors.initials: W
authors.lastname: Singer
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002784:Cholesterol / Q000097:blood*; D002791:Cholesterol, Dietary / Q000008:administration & dosage*; D003327:Coronary Disease / Q000097:blood / Q000453:epidemiology* / Q000517:prevention & control; D004043:Dietary Fiber / Q000008:administration & dosage; D004907:Erythrocyte Deformability; D005260:Female; D006400:Hematocrit; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood* / Q000178:diet therapy*; D008297:Male; D008875:Middle Aged; D009504:Neutrophils; D010840:Phytosterols / Q000008:administration & dosage; D027861:Prunus; D012307:Risk Factors; D030262:Soybean Proteins / Q000008:administration & dosage
chemical_list: D002791:Cholesterol, Dietary; D004043:Dietary Fiber; D010840:Phytosterols; D030262:Soybean Proteins; D002784:Cholesterol